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Abstract To gain insight into presenilin-1 (PS1) structural as-
pects, we explored the structure^function relationship of its
N- and C-terminal (NTF and CTF, respectively) complexes.
We demonstrated that both NTF and CTF act as independent
but inter-changing binding units capable of binding each other
(NTF/CTF) or their homologues (NTF/NTF; CTF/CTF). The
Alzheimer’s disease-associated PS1 mutations Y115H and
M146L do not a¡ect their ability to hetero- and/or homodimer-
ize, thus conserving their basic integrity and function(s). These
results suggest that PS1 associates intra-molecularly to form
higher order complexes, which may be needed for endoproteo-
lytic cleavage and/or Q-secretase-associated activity.
2 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Mutations in the presenilin-1 (PS1) gene account for most
cases of early onset familial Alzheimer’s disease. In vivo, the
PS1 protein is approximately 45^50 kDa in size and under-
goes a proteolytic cleavage by ‘presenilinase’ to generate
N- and C-terminal fragments (NTF and CTF, respectively)
of approximately 32^35 and 16^20 kDa, respectively [1].
PS1 forms also low (V100^180 kDa) and high (s 250 kDa)
molecular weight complexes containing both full-length and
heterodimeric PS1 NTF and CTF fragments [2^5]. Recent
work indicates that the higher molecular weight complexes
contain, among PS1 fragments, at least three other proteins,
namely Nicastrin, Aph-1, and Pen-2 [6,7]. Accumulating evi-
dences tend to demonstrate that the appearance of presenilin
fragments in these complexes is intrinsic to PS1 and Q-secre-
tase activity, is involved in the cleavage of integral membrane
proteins such as amyloid-L precursor protein, Notch1, ErbB4,
etc.
Using the yeast two-hybrid assay and GST pull-down ex-
periments we provide evidence that human PS1 NTF and
CTF moieties can associate directly to form speci¢c hetero-
dimers and that AD-associated PS1 mutations Y115H and
M146L do not a¡ect their ability to hetero-oligomerize. Using
deletion mutants coding for truncated PS1, we demonstrate
that multiple binding regions are implicated in PS1 heterodi-
merization and that both cytoplasmic and transmembrane
(TM) regions are necessary. We also show that PS1 may
self-oligomerize giving rise to NTF/NTF and CTF/CTF ho-
modimers. Although inter-molecular heterodimers have previ-
ously been reported following in situ chemical cross-linking
and co-immunoprecipitation [4,8] ^ which are indirect meth-
ods ^, our data are the ¢rst to con¢rm a direct interaction
between human NTFs and CTFs and identify potential re-
gions of contact under in vivo conditions.
2. Materials and methods
2.1. Yeast two-hybrid assays
cDNA sequences coding for various parts of human PS1 were am-
pli¢ed by PCR using the Herculase Taq polymerase (Stratagene). The
following wild-type (wt) PS1 cDNA were prepared: NTF (PS11291),
1-132 (PS11132), TM1-2 (PS1101153), Loop 1-2 (PS1101132), TM2
(PS1131153), Loop 6-7 (PS1239409), CTF (PS1292467), TM8
(PS1406426), CTF-short (PS1427467). AD-associated PS1 short version
mutants, 1-132 Y115H and TM1-2 M146L were also generated.
cDNAs were cloned both into pGBKT7 and pGADT7 vectors (Clon-
tech) as a fusion to the Gal4-DNA binding domain (BD) and Gal4-
DNA activating domain (AD), respectively. Each construct was se-
quenced and shown to be free of autonomous Gal-4 activation. Func-
tional expression of fusion proteins in yeast was con¢rmed by Western
blot.
Each of the pGBKT7-construct was co-transformed into Y187 or
AH109 Saccharomyces cerevisiae (Clontech) together with each
pGADT7-construct. Transformants were selected on yeast drop-out
media (Clontech) that lacked both tryptophan (Trp) and leucine (Leu)
(TL3) and assayed for L-galactosidase (L-galþ)þ in the case of Y187
and Hisþ and Adeþ activity in the case of AH109. Positive controls
included pGBKT7-p53/pGADT7-T antigen and pGBKT7-PS1-Loop
6-7/pGADT7-hNPRAP as previously described [9].
2.2. Preparation of yeast cell lysates and immunoblotting
Transformed yeasts were harvested by centrifugation and washed
twice in sterile H2O. Pellets were resuspended in V300 Wl of yeast
extraction bu¡er [Tris 50 mM pH 7.5, 150 mM NaCl, 1% CHAPS,
1 mM EDTA, 1 mM PMSF and mini-complete protease inhibitors
(Roche-Diagnostic, Indianapolis, IN, USA)]. Proteins were extracted
using acid washed glass beads (Sigma, St. Louis, MO, USA) as de-
scribed by the manufacturer (Clontech, Palo Alto, CA, USA) and
loaded on a 4^20% NuPAGE gel (Invitrogen) as described above.
Blots were probed with either the anti-c-myc (Roche Diagnostics) or
anti-PS1 PSN2 (gift from Dr. Hiroshi Mori) antibodies.
2.3. GST pull-down assays
PS1-CTF (PS1292467) cDNA was cloned into the pGEX-4T1 vector
and ¢xed on glutathione^Sepharose beads as previously described
[10]. Proteins were eluted from the beads, mixed with 2U sample
bu¡er and V20 Wl was loaded on gel for SDS^PAGE. Blots were
probed with anti-c-myc antibodies (Roche Diagnostics).
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3. Results
3.1. Direct association between PS1 NTF and CTF
Partial PS1 cDNA constructs were produced in order to
represent putative functional domains and sites of multiple
protein interactions. Western blot analysis con¢rmed correct
protein expression for all constructs (Fig. 1B). Although cer-
tain PS1 constructs tested herein contain hydrophobic TM
domains, its fusion to the Gal-4 binding and/or activating
domain in the pGBKT7/pGADT7 vectors reveals over-all pro-
tein solubility (Fig. 1A and [5]). These constructs were shown
to be functional in yeast two-hybrid assays [9^11]. First, we
investigated if our NTF (aa 1^291) of human PS1 could form
a heterodimer with its remaining CTF (aa 292^467). Speci¢c
interaction between NTF (expressed in human HEK293T
cells) and CTF is observed following GST pull-down using
GST-tagged CTF (Fig. 2A). This result corroborates with pre-
vious reports demonstrating NTF/CTF heterodimerization
[4,8]. After this initial result, we tested if NTF/CTF heterodi-
merization could be reproduced in vivo in yeast, a system
lacking both endogenous PS1 and Q-secretase activity [10,12].
As shown in Fig. 2B, interaction between the NTF and CTF is
observed following a L-gal assay using the yeast strain Y187.
To further verify if these two-hybrid interactions were spe-
ci¢c, and not due to non-speci¢c LacZ reporter activation
from strain Y187, we cotransformed all constructs in the
AH109 yeast strain (Clontech). As shown in Fig. 2C, colony
growth on selective medium lacking Ade, His, Trp and Leu
(AHTL3) is observed, con¢rming all L-gal assays. Negative
and positive control experiments were done using empty vec-
tors (either pGBKT7 or pGADT7) and hNPRAP, a known
CTF PS1-interacting protein [9]. Taken together, these results
con¢rm that PS1 NTF and CTF associate directly to form a
stable complex in vivo.
3.2. Mapping of PS1-interacting domains
Using various PS1 cDNA deletion constructs (as shown in
Fig. 1A), we tested which domain(s) was implicated in PS1
Fig. 1. Schematic representation of PS1 fusion proteins. A: Illustration (not to scale) of fusion proteins coding for PS1 generated fragments.
Black squares represent hydrophobic regions corresponding to putative TM domains. Numbers represent the amino acid positions. Kyte^Doo-
little hydrophilicity plots for each construct cloned in fusion with Gal-4 binding and/or activating domains are presented. Value smaller than
1.1 indicates an insoluble protein. B: PS1 engineered fragments cloned in fusion with Gal-4 binding domain were expressed in yeast strain
Y187. Equal amount of 1% CHAPS protein extracts were run on 4^20% NuPAGE, blotted, and probed with anti-myc antibodies. Note:
pGBKT7 empty vector (mock) containing the DNA binding domain (DNA-BD) tagged with c-myc epitope runs at approximately 25 kDa.
Similar results were obtained with PS1 engineered fragments cloned in fusion with Gal-4 activating domain (data not shown).
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NTF/CTF heterodimerization. As summarized in Table 1,
both the 1-132 and the TM1-2 fragments showed interaction
with the PS1-CTF. These observations suggested that PS1 aa
101^132, corresponding to the ¢rst lumenal loop (Loop 1-2),
are implicated in heterodimerization with the CTF. However,
studies using solely the PS1 Loop 1-2 as bait or as target did
not result in positive interactions. As suspected, TM2 did bind
CTF, but weakly. These observations were con¢rm by GST
pull-down assays showing that both TM1-2 and TM2, but not
Loop 1-2 alone or mock (pGBKT7), bind GST-PS1-CTF
(Fig. 3A). We suspect that heterodimerization of PS1 frag-
ments must implicate large intermolecular binding domains
thus possibly ‘taken as a whole’.
Further investigation revealed that 1-132, as contrary to the
TM1-2 fragment, can bind to the cytoplasmic Loop 6-7 (Table
1). This suggests that the ¢rst hydrophilic N-terminus stretch
before TM1 (aa 1^80) may interact with the large cytoplasmic
loop, as they are both oriented to the cytoplasm. Moreover,
since both the TM1-2 and 1-132 bind to CTF but not to CTF-
short our results, altogether, suggest that PS1-NTF/CTF het-
erodimerization is dependent of at least four distant binding
regions: (i) the ¢rst 80 aa portion of PS1-NTF, (ii) the second
lumenal loop combined with the second TM domain (TM1-2),
(iii) the large cytoplasmic loop (Loop 6-7) and (iv) a 61 aa
portion of PS1-CTF (aa 406^467).
3.3. Homodimerization between PS1 NTF and CTF fragments
We have previously reported PS1 full-length/full-length ho-
modimerization in yeast as well as in mammalian cells [5].
Interestingly, we also observe NTF/NTF and CTF/CTF ho-
modimerization (Table 1). We used GST pull-down assays to
con¢rm speci¢c fragment homodimerization using, as exam-
ple, GST-tagged PS1-CTF against expressed PS1-CTF (Fig.
3B).
Crude domain mapping of NTF/NTF homodimerization
led us to demonstrate that both the 1-132 and the TM2 re-
gion, but not Loop 1-2, could bind PS1-NTF (Table 1). Map-
ping of CTF/CTF homodimerization shows that the last 61 aa
portion (aa 406^467) of PS1-CTF, implicated in NTF/CTF
heterodimerization, is required for binding. Since TM8/TM8
(aa 406^426) do not bind to each other and CTF (aa 292^467)
do not bind to CTF-short (aa 427^467) or Loop 6-7 (aa 239^
409), this suggest that the last 61 aa portion of CTF is re-
quired as a whole for binding (Table 1 and Fig. 3B). Taken
together, these results suggest that binding regions implicated
in NTF/CTF heterodimerization are equally important in PS1
fragments homodimerization.
3.4. E¡ects of mutations on hetero- and homodimerization
capacities of PS1-NTF and CTF fragments
We next investigated if mutated PS1-NTF was able to het-
erodimerize with the wt PS1-CTF. We constructed two PS1-
NTFs containing either the Y115H or M146L mutation
(PS11132-Y115H and PS1TM12-M146L). When assayed for
interaction against the PS1-CTF, both mutants showed inter-
action (Table 1). Finally, we tested if these NTF-mutants
Fig. 2. PS1 NTF/CTF heterodimerization. A: 5P-HA-PS1-NTF was expressed in HEK293T cells and equal amounts of 1% CHAPS protein ex-
tracts were incubated with either GST-PS1 CTF or GST alone. Bound material was separated on 4^20% NuPAGE, blotted, and probed with
anti-PSN2. B: Y187 yeast co-transformed colonies were assayed for L-gal activity according to Clontech procedures. Positive interactions were
measured by the blue coloration intensity (++++ represented the highest level and (3) represented absence of coloration). Positive controls in-
clude pGBKT7-p53/pGADT7-T antigen and pGBKT7-PS1-Loop 6-7/pGADT7-hNPRAP. C: AH109 yeast co-transformed colonies were as-
sayed for Hisþ and Adeþ activity according to Clontech procedures. Growth on SD/AHTL3 indicates positive interactions between fusion part-
ners. Growth is indicated by positive (+) signs, where +++ represent the fastest (i.e. early growth observed between 2 and 4 days) rate.
Negative (3) sign indicate absence of growth after 10 days incubation. Results shown represent at least three independent experiences.
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could homodimerize with its wild-type counterpart. Mutants’
oligomerization capabilities appeared similar to their wild-
type counterparts (Table 1). As expected, these PS1 AD-asso-
ciated mutants do not disturb the dimerization suggesting that
PS1 fundamental physiological function is conserved.
4. Discussion
The structure^function analysis of PS1 N- and C-terminal
complexes are important if we consider that both fragments
share putative catalytic elements (within separate TM do-
mains) needed for PS1 enzymatic-related activity(ies) [13]. In
this report, we clearly show direct heterodimerization between
NTF and CTF fragments of PS1. Our results demonstrate
that these two fragments can form heterodimers in vivo. We
also demonstrated that NTF and CTF are capable of self-
association, thus forming homodimers.
Previous studies aimed at understanding PS1 structure and/
or maturation have proposed a model in which PS1 molecules
are ¢rst stabilized then subsequently cleaved to generate the
NTF and CTF [14,15]. Our results support this model and are
also in accordance with the hypothetical ‘tetramer’ model
proposed by Haass and Steiner [16]. Hence, we propose a
new model (Fig. 4) in which PS1 homodimerization precedes
endoproteolytic cleavage by ‘presenilinase’. Following endo-
proteolytic cleavage, formation of a tetramer would be a cru-
Fig. 3. GST pull-down analysis. A: pGBKT7-PS1-TM1-2, pGBKT7-PS1-Loop 1-2, pGBKT7-PS1-TM2 and Mock (pGBKT7) were expressed
in strain Y187, and equal amounts of 1% CHAPS yeast protein extracts were incubated with GST-PS1-CTF. Bound material was separated on
4-20% NuPAGE, blotted, and probed with anti-myc. B: pGBKT7-PS1-Loop 6-7, pGBKT7-PS1-CTF and Mock (pGBKT7) were expressed in
strain Y187, and equal amounts of 1% CHAPS yeast protein extracts were incubated with GST-PS1 CTF. Bound material was separated on
4^20% NuPAGE, blotted, and probed with anti-myc.
Table 1
Summary of regional mapping of PS1 hetero- and homodimerization by yeast two-hybrid assay
pGBKT7+pGADT7 AHTL- pGBKT7+pGADT7 AHTL-
NTF+CTFa +++ Loop 1-2+CTFa 3
NTF+CF short 3 Loop 1-2+CTF short 3
NTF+TM8a 3 Loop 1-2+TM8a 3
NTF+Loop 6-7b 3 Loop 1-2+Loop 6-7 3
NTF+NTF ++ Loop 1-2+NTFa 3
1-132+CTF ++ Loop 1-2+TM2a 3
1-132 H115Y+CTF ++ Loop 1-2+Loop 1-2 3
1-132+CTF short 3 TM2+CTFa +
1-132+TM8 3 TM2+CTF short 3
1-132+Loop 6-7 + TM2+ TM8a 3
1-132+NTF + TM2+Loop 6-7 3
1-132 H115Y+NTF + TM2+NTFa ++
1-132+Loop 1-2 TM2+TM2 3
1-132+TM2 3 Loop 6-7+CTF 3
TM1-2+CTF +++ Loop 6-7+CTF short 3
TM1-2 M146L+CTF +++ Loop 6-7+TM8 3
TM1-2+CTF short 3 Loop 6-7+Loop 6-7 +
TM1-2+TM8 3 Loop 6-7+hNPRAP +++
TM1-2+Loop 6-7 3 CTF+CTF short 3
TM1-2+NTF + CTF+TM8 3
TM1-2+M146L+NTF + TM8+TM8 3
TM1-2+Loop 1-2 3 CTF+CTF ++
TM1-2+TM2 3
Growth activity of selective SD/AHTL-medium is shown. Constructs cloned in DNA-BD (pGBKT7) and GAL4-AD (pGADT7) vectors are
positioned left and right, respectively.
aInverse complement experiences con¢rmed interactions.
bInverse complement experiments gave inconsistent results.
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cial step for the assembly, stability and/or substrate speci¢city
of the high molecular weight presenilin complex necessary for
Q-secretase activity [16]. According to our data, AD-associated
PS1-NTF Y115H and M146L mutants failed to demonstrate a
disrupted interaction with the PS1-CTF. This observation is in
accordance with in vivo studies suggesting that PS1 mutations
lead to a gain of function [17] and not to an abrogated protein
function, as seen in PS1 knock-out mice [18].
Nicastrin, Aph-1 and Pen-2 (presenilin partners in the
Q-secretase complex), the long sought ‘limiting factors’ respon-
sible for stabilization of PS1 endogenous levels, do not seem
to be required for PS1 hetero- and homodimerization, since
no homologues are found in yeast [12]. However, these pro-
teins may be required to saturate, stabilize, generate and/or
limit endogenous levels of mature PS1 in high molecular
weight complexes [12,19].
In an attempt to map domains implicated in NTF/CTF
oligomerization we have demonstrated that both NTF and
CTF act as independent but inter-changing binding units ca-
pable of binding each other (NTF/CTF) or their homologues
(NTF/NTF; CTF/CTF). We propose that each PS1 fragment
acts as pseudo-independent structural units, namely domain A
for the NTF and domain B for the CTF. Other polytopic TM
proteins, such as G-protein coupled receptors, which are
structurally similar to presenilins, do possess two distinct
binding domains [20,21]. AØ priori, hetero-oligomerization of
PS1 domain A seems dependent of its ¢rst 80 aa plus its ¢rst
lumenal loop associated with TM2. However, our results dem-
onstrate that most, if not all, of the domain A is necessary,
perhaps at di¡erent levels, for its intramolecular and possibly
intermolecular protein^protein binding properties. Recent
¢ndings showing that the ¢rst 1^132 portion of the NTF,
and most importantly but not exclusively, the ¢rst TM do-
main are needed to bind APP and/or telencephanin [22] are in
accordance with this hypothesis. Of particular importance,
other reports have associated the ¢rst two TM domains as
crucial for PS1 stability, endoproteolysis and cellular matura-
tion [1,23].
Like its N-terminal counterpart, most of the PS1-CTF frag-
ment (domain B) seems implicated in heterodimerization and/
or homodimerization. Our results are in agreement with pre-
vious reports which, in sum, pinpoint di¡erent portions lo-
cated at the C-terminus of PS1-CTF implicated in PS1 matu-
ration and/or Q-secretase-associated activity [1,24,25].
Taken together, our results clearly demonstrate that PS1
and its endoproteolytic fragments may undergo self-dimeriza-
tion in vivo. Because PS1 NTF and CTF generated fragments
represent important AD therapeutic targets, their physiologi-
cal existence as homo- or hetero-oligomers could have impor-
tant implications for the development and screening of new
drugs.
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Fig. 4. Hypothetical model of PS1 maturation. Nascent PS1 is ex-
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